SHAMROIN.BO · BSE
SHAMROCK INDUSTRIAL CO.LTD.
₹27.25
+4.97% (+₹1.29)
Prev. close
₹25.96
Volume
757
As of
15 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About SHAMROCK INDUSTRIAL CO.LTD.
Shamrock Industrial Company Limited does not have significant operations. It intends to manufacture and trade in pharmaceutical products and services. Shamrock Industrial Company Limited was incorporated in 1991 and is based in Mumbai, India.
Details
Sector
Healthcare
Industry
Medical Distribution
CEO
Mr. Aryan Chand
Headquarters
Mumbai
Exchange
View on BSE ↗Key stats
Market cap
₹14.79 Cr
EPS (TTM)
₹-1.98
Beta (1Y · daily vs NIFTY 50)
-0.04
Beta (5Y · monthly vs NIFTY 50)
0.70
Shares float
24.93 L
EPS · quarter ended Jun 2026
₹-0.19
Financial Performance
01 · Financials
02 · Earnings Per Share (EPS)
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹0 | ₹0 | ₹0 | ₹2.60 L | |
| EBITDA | ₹-12.78 L | ₹-4.06 L | ₹-12.60 L | ₹-1.09 Cr |
| ₹-12.85 L | ₹-4.06 L | ₹-12.60 L | ₹-1.09 Cr | |
| Diluted EPS | ₹-0.24 | ₹-0.07 | ₹-0.23 | ₹-2 |
Total expenses (as filed), Employee benefit expense, Other expenses have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹1.80 Cr | ₹1.76 Cr | ₹1.64 Cr | ₹1.66 Cr | |
| ₹0 | ₹0 | ₹0 | ₹66.12 L | |
| Stockholders' equity | ₹1.77 Cr | ₹1.73 Cr | ₹1.60 Cr | ₹51.57 L |
Long-term debt, Others have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹-3.50 L | ₹-3.67 L | ₹-12.99 L | ₹-1.04 Cr | |
| Investing cash flow | ₹0 | ₹0 | ₹-78.74 L | ₹-3.36 L |
| ₹0 | ₹0 | ₹0 | ₹1.07 Cr | |
| End cash position | ₹96.77 L | ₹93.10 L | ₹1.37 L | ₹1.18 L |
Debt issued has filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source has no quarterly cash-flow-statement coverage.
12 · Peer Comparison
Healthcare
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4.48 L Cr | ₹1,837.3 | 37.0 | 5.36 | 13.7% | 0.06 | +11.9% | +11.4% |
| Divi's Laboratories Limited | ₹2.47 L Cr | ₹9,375 | 83.3 | 14.77 | 15.3% | 0.00 | +12.3% | +53.4% |
| Torrent Pharmaceuticals Limited | ₹1.83 L Cr | ₹4,875 | 76.9 | 21.82 | 25.8% | 1.79 | +21.5% | +37.4% |
| Apollo Hospitals Enterprise Limited | ₹1.26 L Cr | ₹8,944.5 | 60.4 | 13.30 | 20.5% | 0.90 | +15.7% | +13.9% |
| Lenskart Solutions Limited | ₹1.18 L Cr | ₹707.2 | 179.9 | 13.48 | 5.6% | 0.35 | +35.4% | — |
| Zydus Lifesciences Limited | ₹1.13 L Cr | ₹1,160 | 25.3 | 4.18 | 18.6% | 0.46 | +18.4% | +10.7% |
| Cipla Limited | ₹1.10 L Cr | ₹1,376.3 | 32.5 | 3.19 | 11.3% | 0.02 | +2.1% | -11.8% |
| Laurus Labs Limited | ₹1.05 L Cr | ₹1,954 | 96.4 | 19.86 | 16.8% | 0.48 | +22.0% | +111.6% |
| Max Healthcare Institute Limited | ₹1.01 L Cr | ₹1,049.3 | 69.8 | 9.39 | 13.4% | 0.32 | +19.0% | -10.6% |
| Dr. Reddy's Laboratories Limited | ₹97,876.16 Cr | ₹1,185 | 29.6 | 2.60 | 11.4% | 0.21 | +3.2% | -10.4% |
| Manipal Health Enterprises Limited | ₹97,364.22 Cr | ₹738.95 | 146.6 | 11.56 | 7.8% | 1.53 | +18.0% | — |
| SHAMROCK INDUSTRIAL CO.LTD. | ₹14.79 Cr | ₹27.25 | — | 28.68 | -210.7% | 1.28 | — | +62.5% |
Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Show all 22
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.